174 related articles for article (PubMed ID: 12130513)
41. Activation of HOX11L2 by juxtaposition with 3'-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2).
MacLeod RA; Nagel S; Kaufmann M; Janssen JW; Drexler HG
Genes Chromosomes Cancer; 2003 May; 37(1):84-91. PubMed ID: 12661009
[TBL] [Abstract][Full Text] [Related]
42. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
[TBL] [Abstract][Full Text] [Related]
43. High incidence of Hox11L2 expression in children with T-ALL.
Mauvieux L; Leymarie V; Helias C; Perrusson N; Falkenrodt A; Lioure B; Lutz P; Lessard M
Leukemia; 2002 Dec; 16(12):2417-22. PubMed ID: 12454747
[TBL] [Abstract][Full Text] [Related]
44. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study.
Bash RO; Crist WM; Shuster JJ; Link MP; Amylon M; Pullen J; Carroll AJ; Buchanan GR; Smith RG; Baer R
Blood; 1993 Apr; 81(8):2110-7. PubMed ID: 8471769
[TBL] [Abstract][Full Text] [Related]
45. Identification of DeltaEF1 as a novel target that is negatively regulated by LMO2 in T-cell leukemia.
Sun W; Yang S; Shen W; Li H; Gao Y; Zhu TH
Eur J Haematol; 2010 Dec; 85(6):508-19. PubMed ID: 20731704
[TBL] [Abstract][Full Text] [Related]
46. Thymic adult T-cell acute lymphoblastic leukemia stratified in standard- and high-risk group by aberrant HOX11L2 expression: experience of the German multicenter ALL study group.
Baak U; Gökbuget N; Orawa H; Schwartz S; Hoelzer D; Thiel E; Burmeister T;
Leukemia; 2008 Jun; 22(6):1154-60. PubMed ID: 18368072
[TBL] [Abstract][Full Text] [Related]
47. FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2.
Fleskens V; Mokry M; van der Leun AM; Huppelschoten S; Pals CE; Peeters J; Coenen S; Cardoso BA; Barata JT; van Loosdregt J; Coffer PJ
Oncogene; 2016 Aug; 35(31):4141-8. PubMed ID: 26686090
[TBL] [Abstract][Full Text] [Related]
48. Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of STIL/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis.
Skalska-Sadowska J; Dawidowska M; Szarzyńska-Zawadzka B; Jarmuż-Szymczak M; Czerwińska-Rybak J; Machowska L; Derwich K
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27759908
[TBL] [Abstract][Full Text] [Related]
49. The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1.
Shields BJ; Slape CI; Vo N; Jackson JT; Pliego-Zamora A; Ranasinghe H; Shi W; Curtis DJ; McCormack MP
Leukemia; 2019 Aug; 33(8):1868-1880. PubMed ID: 30700838
[TBL] [Abstract][Full Text] [Related]
50. PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events.
Mendes RD; Sarmento LM; Canté-Barrett K; Zuurbier L; Buijs-Gladdines JG; Póvoa V; Smits WK; Abecasis M; Yunes JA; Sonneveld E; Horstmann MA; Pieters R; Barata JT; Meijerink JP
Blood; 2014 Jul; 124(4):567-78. PubMed ID: 24904117
[TBL] [Abstract][Full Text] [Related]
51. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia.
Pongers-Willemse MJ; Seriu T; Stolz F; d'Aniello E; Gameiro P; Pisa P; Gonzalez M; Bartram CR; Panzer-Grümayer ER; Biondi A; San Miguel JF; van Dongen JJ
Leukemia; 1999 Jan; 13(1):110-8. PubMed ID: 10049045
[TBL] [Abstract][Full Text] [Related]
52. [Detection of fusion genes resulting from chromosome abnormalities in childhood acute lymphoblastic leukemia].
He J; Chen ZX; Xue YQ; Li JQ; He HL; Huang YP; He YX; Chai YH; Zhu LL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):551-3. PubMed ID: 16215946
[TBL] [Abstract][Full Text] [Related]
53. The translocation (1;14)(p34;q11) in human T-cell leukemia: chromosome breakage 25 kilobase pairs downstream of the TAL1 protooncogene.
Xia Y; Brown L; Tsan JT; Yang CY; Siciliano MJ; Crist WM; Carroll AJ; Baer R
Genes Chromosomes Cancer; 1992 Apr; 4(3):211-6. PubMed ID: 1382561
[TBL] [Abstract][Full Text] [Related]
54. A single split-signal FISH probe set allows detection of TAL1 translocations as well as SIL-TAL1 fusion genes in a single test.
van der Burg M; Smit B; Brinkhof B; Barendregt BH; Verschuren MC; Dib M; Beverloo HB; van Dongen JJ; Langerak AW
Leukemia; 2002 Apr; 16(4):755-61. PubMed ID: 11960364
[TBL] [Abstract][Full Text] [Related]
55. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease.
Szczepański T; Langerak AW; Wolvers-Tettero IL; Ossenkoppele GJ; Verhoef G; Stul M; Petersen EJ; de Bruijn MA; van't Veer MB; van Dongen JJ
Leukemia; 1998 Jul; 12(7):1081-8. PubMed ID: 9665194
[TBL] [Abstract][Full Text] [Related]
56. TAL1 expression does not occur in the majority of T-ALL blasts.
Delabesse E; Bernard M; Meyer V; Smit L; Pulford K; Cayuela JM; Ritz J; Bourquelot P; Strominger JL; Valensi F; Macintyre EA
Br J Haematol; 1998 Jul; 102(2):449-57. PubMed ID: 9695959
[TBL] [Abstract][Full Text] [Related]
57. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites.
Marculescu R; Le T; Simon P; Jaeger U; Nadel B
J Exp Med; 2002 Jan; 195(1):85-98. PubMed ID: 11781368
[TBL] [Abstract][Full Text] [Related]
58. Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities.
Sánchez-García I; Rabbitts TH
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7869-73. PubMed ID: 8058726
[TBL] [Abstract][Full Text] [Related]
59. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA
Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790
[TBL] [Abstract][Full Text] [Related]
60. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
O'Neil J; Billa M; Oikemus S; Kelliher M
Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
